ES2059121T5 - Uso de agentes sensibilizantes de la insulina para tratar la hipertension. - Google Patents
Uso de agentes sensibilizantes de la insulina para tratar la hipertension.Info
- Publication number
- ES2059121T5 ES2059121T5 ES91904163T ES91904163T ES2059121T5 ES 2059121 T5 ES2059121 T5 ES 2059121T5 ES 91904163 T ES91904163 T ES 91904163T ES 91904163 T ES91904163 T ES 91904163T ES 2059121 T5 ES2059121 T5 ES 2059121T5
- Authority
- ES
- Spain
- Prior art keywords
- insulin sensitizing
- treat hypertension
- sensitizing agents
- insulin
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UN METODO PARA EL TRATAMIENTO DE LA HIPERTENSION EN PACIENTES RESISTENTES A INSULINA QUE COMPRENDE LA ADMINISTRACION DE UN AGENTE DE SENSIBILIZACION DE INSULINA, PARTICULARMENTE CIGLITAZONA O PIOGLITAZONA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47809090A | 1990-02-09 | 1990-02-09 | |
PCT/US1991/000348 WO1991012003A1 (en) | 1990-02-09 | 1991-01-23 | Use of insulin sensitizing agents to treat hypertension |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2059121T3 ES2059121T3 (es) | 1994-11-01 |
ES2059121T5 true ES2059121T5 (es) | 2000-12-01 |
Family
ID=23898474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91904163T Expired - Lifetime ES2059121T5 (es) | 1990-02-09 | 1991-01-23 | Uso de agentes sensibilizantes de la insulina para tratar la hipertension. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0514452B2 (es) |
JP (1) | JP3544659B2 (es) |
KR (1) | KR0170416B1 (es) |
AT (1) | ATE93138T1 (es) |
AU (1) | AU651571B2 (es) |
CA (1) | CA2071629C (es) |
DE (1) | DE69100282T3 (es) |
DK (1) | DK0514452T4 (es) |
ES (1) | ES2059121T5 (es) |
GR (1) | GR3034508T3 (es) |
HK (1) | HK153996A (es) |
WO (1) | WO1991012003A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175179A (en) * | 1991-09-25 | 1992-12-29 | Pfizer Inc. | Method for treating hypertension |
US5874454A (en) * | 1993-09-15 | 1999-02-23 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
US6046222A (en) * | 1993-09-15 | 2000-04-04 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US5594015A (en) * | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
US5925656A (en) * | 1995-04-10 | 1999-07-20 | Dr. Reddy's Research Foundation | Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
SI0914158T2 (sl) * | 1996-04-05 | 2006-04-30 | Takeda Chemical Industries Ltd | Farmacevtska kombinacija, ki vsebuje spojino z angiotenzin II-antagonisticno aktivnostjo in spojino, ki povecuje inzulinsko obcutljivost |
AU2381397A (en) * | 1996-04-19 | 1997-11-12 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
US5958957A (en) * | 1996-04-19 | 1999-09-28 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
ZA973850B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
US5919782A (en) * | 1996-05-06 | 1999-07-06 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
ZA973848B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
US5801173A (en) * | 1996-05-06 | 1998-09-01 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
CA2257284C (en) * | 1996-05-31 | 2005-10-04 | Sankyo Company Limited | Remedy for autoimmune diseases |
KR20000016074A (ko) * | 1996-05-31 | 2000-03-25 | 가와무라 요시부미 | 자기면역질환 치료제 |
US6114526A (en) | 1996-07-01 | 2000-09-05 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
KR100579765B1 (ko) | 1996-07-01 | 2006-12-28 | 닥터 레디스 레보러터리즈 리미티드 | 신규헤테로고리형화합물의제조방법,이를함유하는약제조성물및당뇨병및이와관련된질병의치료에있어서그의용도 |
USRE39266E1 (en) * | 1996-07-01 | 2006-09-05 | Dr. Reddy's Laboratories, Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
US5885997A (en) * | 1996-07-01 | 1999-03-23 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
US6372750B2 (en) | 1996-07-01 | 2002-04-16 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
US6011036A (en) * | 1997-04-15 | 2000-01-04 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them |
US6011031A (en) * | 1997-05-30 | 2000-01-04 | Dr. Reddy's Research Foundation | Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them |
WO1999024429A1 (fr) * | 1997-11-12 | 1999-05-20 | Kyoto Pharmaceutical Industries, Ltd. | Nouveaux composes thiazolidine et utilisation de ceux-ci en medecine |
TR200101336T2 (tr) * | 1998-11-11 | 2001-11-21 | Smithkline Beecham P.L.C. | Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar |
PE20010580A1 (es) * | 1999-09-03 | 2001-05-25 | Takeda Chemical Industries Ltd | Composicion farmaceutica para tratar la diabetes |
EP2638898A1 (en) | 2012-03-16 | 2013-09-18 | Sanovel Ilac Sanayi ve Ticaret A.S. | Metformin and Pioglitazone Formulation with Different Release Profiles |
MA39929A (fr) | 2014-11-27 | 2016-06-01 | Arven Ilac Sanayi Ve Ticaret As | Comprimé multicouche comprenant de la metformine et du pioglitazone |
TR201620309A2 (tr) | 2016-12-30 | 2018-07-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇ |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3542927A (en) * | 1965-08-10 | 1970-11-24 | Pfizer | Reduction of blood sugar levels with aminomethylindoles |
EP0006735B1 (en) * | 1978-06-28 | 1983-06-15 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
EP0052963B1 (en) * | 1980-11-20 | 1985-02-20 | Beecham Group Plc | Secondary amines |
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
EP0142102B1 (en) † | 1983-11-04 | 1987-09-23 | Beecham Group Plc | Tertiary amines |
US4602044A (en) † | 1983-12-19 | 1986-07-22 | Eli Lilly And Company | β-phenethanolamine antiobesity agents |
DE3419935A1 (de) * | 1984-05-28 | 1985-11-28 | Merck Patent Gmbh, 6100 Darmstadt | Verwendung von hydroxyindolderivaten bei der senkung des blutdrucks |
AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
GB8607312D0 (en) † | 1986-03-25 | 1986-04-30 | Ici Plc | Therapeutic agents |
FR2611500B1 (fr) * | 1987-03-06 | 1990-05-04 | Lipha | Emploi de derives du biguanide dans la preparation de medicaments |
IE62214B1 (en) * | 1988-05-25 | 1995-01-11 | Warner Lambert Co | Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents |
GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
-
1991
- 1991-01-23 WO PCT/US1991/000348 patent/WO1991012003A1/en active IP Right Grant
- 1991-01-23 DK DK91904163T patent/DK0514452T4/da active
- 1991-01-23 CA CA002071629A patent/CA2071629C/en not_active Expired - Fee Related
- 1991-01-23 AU AU72416/91A patent/AU651571B2/en not_active Ceased
- 1991-01-23 ES ES91904163T patent/ES2059121T5/es not_active Expired - Lifetime
- 1991-01-23 DE DE69100282T patent/DE69100282T3/de not_active Expired - Fee Related
- 1991-01-23 JP JP50440791A patent/JP3544659B2/ja not_active Expired - Fee Related
- 1991-01-23 EP EP91904163A patent/EP0514452B2/en not_active Expired - Lifetime
- 1991-01-23 AT AT91904163T patent/ATE93138T1/de not_active IP Right Cessation
- 1991-01-23 KR KR1019920701906A patent/KR0170416B1/ko not_active IP Right Cessation
-
1996
- 1996-08-08 HK HK153996A patent/HK153996A/xx not_active IP Right Cessation
-
2000
- 2000-09-28 GR GR20000402198T patent/GR3034508T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2071629A1 (en) | 1991-08-10 |
ES2059121T3 (es) | 1994-11-01 |
EP0514452B2 (en) | 2000-07-19 |
AU651571B2 (en) | 1994-07-28 |
DK0514452T3 (da) | 1993-11-29 |
KR0170416B1 (ko) | 1999-02-18 |
DE69100282T2 (de) | 1994-01-05 |
JP3544659B2 (ja) | 2004-07-21 |
EP0514452A1 (en) | 1992-11-25 |
JPH05506430A (ja) | 1993-09-22 |
DE69100282T3 (de) | 2001-01-11 |
WO1991012003A1 (en) | 1991-08-22 |
ATE93138T1 (de) | 1993-09-15 |
AU7241691A (en) | 1991-09-03 |
EP0514452B1 (en) | 1993-08-18 |
DK0514452T4 (da) | 2000-09-18 |
DE69100282D1 (de) | 1993-09-23 |
HK153996A (en) | 1996-08-16 |
CA2071629C (en) | 1997-12-30 |
GR3034508T3 (en) | 2000-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2059121T5 (es) | Uso de agentes sensibilizantes de la insulina para tratar la hipertension. | |
TR199902033T2 (xx) | Diyabet i�in s�lfonilura-glitazon sinerjik kombinasyonlar�. | |
SE9404196D0 (sv) | New antithrombotic formulation | |
NO20074774L (no) | Blandinger omfattende DNA-odeleggende midler og P53 | |
BG95935A (bg) | Метод и средство за приемане на дексмедетомидин директно през кожата | |
LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
ES2035384T3 (es) | Procedimiento para la esterilizacion de sangre, plasma, derivados de la sangre y del plasma, suspensiones celulares o similares. | |
DK0473671T3 (da) | Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel | |
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
MX9205127A (es) | Una composicion farmaceutica y un metodo para usar una combinacion de un agente uricosurico y un antagonista eaa. | |
DK0432117T3 (da) | Farmaceutisk præparat til behandling af inflammation | |
BR9908510A (pt) | Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana | |
LV11894A (lv) | Jauni hromana un tiohromana atvasinajumi | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
DK0468258T3 (da) | Substituerede pyridooxaziner | |
BR0015402A (pt) | Derivados de ácido 15-hidroxieicosatetraenóico de cadeia Èmega modificada e métodos de seu uso para o tratamento de olho seco | |
ES2059058T3 (es) | Combinacion sinergica para uso oftalmico. | |
BR9708037A (pt) | Método para o tratamento de abuso de substância | |
SE9500897D0 (sv) | The pharmacological use of certain cystine derivatives | |
SE9101341D0 (sv) | New medicinal use | |
ES2129401T3 (es) | Uso de un compuesto terapeutico para el tratamiento de bronquitis. | |
DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine | |
PT1304107E (pt) | Utilizacao de derivados de oxazolidininas para o tratamento da psoriase | |
BR0314647A (pt) | Uso de derivados de 4-piridilmetil-ftalazina para a preparação de um medicamento para o tratamento de sìndromes melodisplásicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 514452 Country of ref document: ES |